P3.04-004 Treatment Rationale and Study Design for the TAKUMI Trial
نویسندگان
چکیده
منابع مشابه
Design and Rationale of the APELOT Trial
Ticagrelor is a direct acting on the P2Y12 receptor blocker, which provides faster and greater platelet inhibition than clopidogrel. However, several studies suggested that in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention (PCI), ticagrelor exhibits initial delay in the onset of antiplatelet action. Unlike ST-segment elevation myocardial infarc...
متن کاملThe MeTeOR Trial: Rationale and Design Features
The MeTeOR Trial: Rationale and Design Features Jeffrey N. Katz, MD, MSc 1 Christine E. Chaisson, MPH 2 Brian Cole, MD, MBA 3 Ali Guermazi, MD 4 David J. Hunter, MBBS, PhD 5 Morgan Jones, MD, MPH 6 Bruce A. Levy, MD 7 Lisa A. Mandl, MD, MPH 8 Scott Martin, MD 1 Robert G. Marx, MD, MSc 8 Clare Safran-Norton, PT, PhD 1 Frank W. Roemer, MD 4, 9 Debra Skoniecki, RNP 1 Daniel H. Solomon, MD, MPH 1 K...
متن کاملRationale and design for the PAINT randomized trial.
BACKGROUND We describe the rationale and design for the 'PercutAneous INTervention with biodegradable-polymer based paclitaxel-eluting or sirolimus-eluting versus bare stents for de novo coronary lesions - PAINT trial'. OBJECTIVES To evaluate two novel formulations of paclitaxel-eluting stent and the sirolimus-eluting stent against a stent with the same metallic structure but without polymer ...
متن کاملdeveloping a pattern based on speech acts and language functions for developing materials for the course “ the study of islamic texts translation”
هدف پژوهش حاضر ارائه ی الگویی بر اساس کنش گفتار و کارکرد زبان برای تدوین مطالب درس "بررسی آثار ترجمه شده ی اسلامی" می باشد. در الگوی جدید، جهت تدوین مطالب بهتر و جذاب تر، بر خلاف کتاب-های موجود، از مدل های سطوح گفتارِ آستین (1962)، گروه بندی عملکردهای گفتارِ سرل (1976) و کارکرد زبانیِ هالیدی (1978) بهره جسته شده است. برای این منظور، 57 آیه ی شریفه، به صورت تصادفی از بخش-های مختلف قرآن انتخاب گردید...
15 صفحه اولA randomized clinical trial of unfractioned heparin for treatment of sepsis (the HETRASE study): design and rationale [NCT00100308]
INTRODUCTION Infection promotes coagulation via a large number of molecular and cellular mechanisms, and this procoagulant activity has boosted basic and clinical research using anticoagulant molecules as therapeutic tools in sepsis. Heparin, which is a naturally occurring proteoglycan that acts by reducing thrombin generation and fibrin formation, has not been rigorously tested in a randomized...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Thoracic Oncology
سال: 2017
ISSN: 1556-0864
DOI: 10.1016/j.jtho.2017.09.1662